TrialScientific reports2026

Efficacy and safety of DMB-I (latrepirdine) therapy in mild to moderate dementia in Alzheimer's disease: results of a multicenter, double-blind, randomized, placebo-controlled, clinical trial in three parallel groups.

Boris I Gorin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.